From a diabetes educator’s perspective it is interesting to note that despite your son being recently diagnosed with T1DM, his daily insulin requirements have been reduced, at times, to only 3 units of a rapid acting insulin? Would this represent a large reduction from his previous daily requirements?
It is also interesting to see that he only experienced transient headaches during the (8 day) dosing period for the Defend-2 trial. I am hoping that they were treatable and allowed him to enjoy the normal daily activities of a 12 year old.
It will be interesting to see if the recent reduction in blood glucose levels fluctuations that you described is a phenomenon that is enduring.